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Aim: Heart failure (HF) is a serious complication of acute myocardial infarction (AMI) 
leading to poor prognosis. We aimed at exploring time trends of HF and its impact on 
mortality among patients with an incident AMI. 
Methods: We collected from the National Patient Danish Registry (NPDR) all patients 
hospitalized with an incident AMI during 2001-2009 and identified cases with in-hospital HF 
(presented on admission or developing HF during AMI hospitalization) or post-discharge HF 
(an hospitalization or outpatient visit following AMI discharge) and assessed in-hospital, 30-
day and one-year mortality. 
Results: Of 78 814 patients included in the study, 10 248 (13.0%) developed in-hospital HF. 
The odds of in-hospital HF declined 0.9% per year [odds ratio (OR)=0.991, 95% CI: 0.983–
0.999]. In-hospital HF was associated with 13% (OR=1.13, 95% CI: 1.06–1.20) and 14% 
(OR=1.14, 95% CI: 1.07–1.20) higher in-hospital and 30-day mortality, respectively. 
Of 61 637 patients discharged alive, without in-hospital HF, 5978 (9.7%) experienced post-
discharge HF; 4116 (6.7%) were hospitalized and 1862 (3.0%) diagnosed at outpatient clinics. 
The risk of HF requiring hospitalization declined 5.5% per year [hazard ratio (HR)=0.945, 
95% CI: 0.934–0.955] while the risk of HF diagnosed at outpatient clinics increased 13.4% 
per year (HR=1.134, 95% CI: 1.115–1.153). Post-discharge HF was associated with 239% 
(HR=3.39, 95% CI: 3.18–3.63) higher one-year mortality. 
Conclusion: In-hospital and post-discharge HF requiring hospitalization decreased while 
post-discharge HF diagnosed at outpatient clinics increased among incident AMI patients 
during 2000-2009. The development of HF - especially after AMI discharge - indicate a poor 
prognosis. 





Heart failure (HF) is a serious health condition affecting 38 million patients worldwide 1. Its 
prevalence is increasing 2 due to improved survival of cardiac patients and aging of the 
population. 
Coronary heart disease (CHD) is the most common underlying condition for HF 3 4. The risk 
of HF in influenced by many factors, including clinical presentation and anatomical extend of 
CHD, quality of acute coronary care, prior use of cardiac drugs in the primary and secondary 
prevention setting and burden of comorbidities. The complex interplay between these factors - 
each displaying individual trends – make it difficult the prediction of trends of HF over time 
in coronary patients. This, is reflected by the discrepant results of published studies, with 
some demonstrating increases 5 6 and others declines 7-10 in the risk of HF among coronary 
patients. 
The negative effect of HF among AMI patients has mainly been studied in association with 
short-term mortality 11-13 . Few studies have extended the follow up beyond discharge. Of 
those, some did not distinguish between in-hospital or post-discharge HF 9 14 and others 
included a mixture of incident and prevalent AMI cases 15. A recent nationwide analysis from 
Norway focusing on the excess mortality associated with post-discharge HF, could only 
identify HF cases requiring hospitalization due to the lack of data from outpatient clinics 16. 
Using data from the Danish National Patient Registry (DNPR) we aimed at i) exploring trends 
in the risk of HF (separately for in-hospital and post-discharge HF) as a complication of an 
incident AMI and ii) assessing the prognostic impact of HF on short and long-term mortality 






Materials and methods 
The DNPR has collected information on in-patients from all somatic (from 1977) and 
psychiatric (from 1995) hospitals as well as outpatient contacts (from 1995) in Denmark. 
Detailed information on the content, structure and quality of data in the registry is provided 
here 17. Shortly, data in the DNPR include patient’s age, gender, admission and discharge 
dates, one primary and all secondary discharge diagnoses as well as information on medical 
diagnostic and treatment procedures.  
The positive predictive values (PPV) of first time AMI in the DNPR is >90%18 while the HF 
diagnosis has a somehow lower PPV (80%) 18 19 but a very high specificity (99%)19. Cardiac 
procedures relevant to this study have a very high PPV (100% for coronary angiography and 
98% for PCI and CABG)20.  
The Danish Civil Registration System was established in 1968 for administrative purposes 21. 
It assigns a unique Civil Personal Register number to all persons residing in Denmark, 
allowing individual-level linkages between different registers. 
For these analyses, we identified all Danish residents ≥ 40 years, hospitalized with an incident 
AMI (ICD–10 codes, I21, I22) as the primary discharge diagnosis from 1 January 2000 to 31 
December 2009. We excluded from the analyses patients a) with history of HF (ICD–10 
codes, I11.0, I13.0, I13.2, I42.0, I42.2; I42.6; I42.7, I42.8; I42.9; I50.0; I50.1; I50.2; I50.3; 
I50.8 and I50.9) prior to incident AMI hospitalization, b) missing information on age and/or 
gender and c) unusually long hospital stays (> 99th percentile of the hospital stay distribution). 
Clinically relevant complications during the incident of AMI included pulmonary edema 
(J81), cardiogenic shock (R57.0), second (I44.1) or third (I44.2) degree atrioventricular block 





We followed patients up to one year from incident AMI discharge. New episodes of HF were 
classified based on their timing in relation to the incident AMI hospitalization into two 
mutually exclusive categories; HF presented on admission or developing during AMI 
hospitalization (in-hospital HF) and a new hospitalization or outpatient visit with a HF 
diagnosis following AMI discharge (post-discharge HF). In the analyses of post-discharge 
HF, we included only patients discharged without in-hospital HF from the incident AMI 
hospitalization. 
The diagnosis of HF was based on ICD–10 codes suggestive for HF (I11.0, I13.0, I13.2, 
I42.0, I42.2; I42.6; I42.7, I42.8; I42.9; I50.0; I50.1; I50.2; I50.3; I50.8 and I50.9). 
We estimated the excess mortality associated with HF by calculating the ratio of risk of dying 
between AMI patients with HF and those without HF. We estimated the impact of in-hospital 
HF on in-hospital and 30-day mortality and the impact of post-discharge HF on one-year 
mortality. 
Data analyses 
Categorical variables are presented as proportions and continuous variables as mean and 
standard deviation (SD) or median and interquartile range (IQR). 
Trends of in-hospital HF were explored using logistic regression and results presented as odds 
ratios (ORs) and corresponding 95% confidence intervals (CIs). To account for the potential 
competing effect of early deaths on in-hospital HF occurrence, we conducted additional 
analyses, including only patients who survived the first AMI hospitalization day. 
Trends of post-discharge HF were explored using Cox regression models and results 
presented as hazard ratios (HRs) and corresponding 95% CIs. In addition to overall analyses, 




The impact of in-hospital HF on early (in-hospital and 30-day) mortality was explored using 
logistic regression. The impact of post-discharge HF on one-year mortality was explored 
using Cox models with HF as a time-varying covariate.  
Models were adjusted for age, sex and relevant comorbidities which a) predict HF 3 22 
[hypertension, (ICD–10 codes, I10–I15), diabetes mellitus (DM) (ICD–10 codes, E10–E14), 
renal failure (ICD–10 codes, N17–N19), chronic obstructive pulmonary disease (COPD) 
(ICD–10 codes, J40–J44, J47), valvular heart disease (ICD–10 codes, I05–I09; I34–I35) and 
atrial fibrillation (ICD–10 code, I48)] and b) showed different distribution among AMI 
patients across study years. These covariates were identified through discharge diagnoses 
(primary or secondary) from previous hospitalizations or outpatient visits within five years 


















Study population and excluding criteria 
Information on selecting procedures, study population and outcomes is provided in Figure 1. 
Of 86 055 eligible patients, 1224 patients lacked information on age and gender, 5206 patients 
had history of HF and 811 patients had long AMI hospital stays. At the end, 78 814 patients 
were included in the analyses. 
Baseline characteristics of study participants 
Patients’ age declined while the prevalence of comorbidities increased over the study 
period. The proportion of patients with AMI complications was generally low and did not 
show a clear trend while utilization of invasive coronary procedures increased substantially 
over time (Table 1). The length of AMI hospitalization shortened over time in both men and 
women (both age-adjusted Ptrend<0.001) (Supplemental material, Table S1). 
Time trends in heart failure 
Overall, 13.0% of AMI patients developed in-hospital HF (Table 2). Adjusted analyses 
revealed a relatively small decline in the odds of in-hospital HF (0.9% per year; Ptrend<0.001) 
(Figure 2). Restricting the analyses to 76 874 patients surviving the first hospitalization day, 
yielded very similar results to those of the main analyses (a 
decline of 1.0% per year; Ptrend<0.001). 
Of patients discharged alive, without in-hospital HF, another 9.7% developed post-discharge 
HF (Table 2). The adjusted risk of overall post-discharge HF did not change significantly 
during the study period (Supplemental material, Figure S1). When analyzed separately, the 
risk of HF requiring hospitalization declined 5.5% per year while the risk of HF diagnosed in 
outpatient settings increased 13.4% per year (both Ptrend<0.001) (Figure 3). 
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HF cases requiring hospitalizations outnumbered those diagnosed at outpatient clinics. Over 
time, the diagnostic settings of post-discharge HF shifted from hospitals to outpatient clinics 
(Supplemental material, Table S2). To illustrate, the proportion of post-discharge HF cases 
required hospitalization dropped from 82.0% in 2000-2001 to 53.3% in 2008-2009. 
The baseline characteristics of patients with post-discharge HF according to diagnostic setting 
are given in the Supplemental material (Table S3). Hospitalized cases were older, more often 
women, had a higher burden of comorbidities and received less often invasive coronary 
procedures compared to patients diagnosed with HF at outpatient clinics. We observed a 
shorter time from AMI discharge to HF diagnosis for outpatient contacts compared to those 
requiring hospitalization. (Supplemental material, Table S3).                                  
Prognostic impact of heart failure  
Overall, 10.7% of patients did not survive the incident AMI hospitalization. Among patients 
discharged without in-hospital HF, 9.6% died within one year from AMI discharge (Table 2). 
Among AMI patients without in-hospital HF, 10.1% died at the hospital. The corresponding 
proportion among those with in-hospital HF was 14.8% (Table 3).  
In-hospital HF was associated with 1.13 times higher odds (OR=1.13, 95% CI: 1.06–1.20) of 
dying at the hospital and 1.14 time higher odds (OR=1.14, 95% CI: 1.07–1.20) of dying 
within 30 days of AMI hospitalization (Table 3). 
Post-discharge HF was associated with 3.39 times higher HF (HR=3.39, 95% CI: 3.18–3.63) 
one-year mortality (Table 4). 
Over the study period, the excessive mortality associated with HF changed significantly (in-
hospital mortality: Pinteraction=0.001; 30-day mortality: Pinteraction=0.003 and one-year mortality: 
Pinteraction=0.008) but these changes did not display a clear increasing or decreasing trend 




Among patients hospitalized with an incident AMI in Denmark during 2000-2009, the risk of 
in-hospital HF slightly declined while the overall risk of post-discharge HF did not change 
over time. The proportion of HF cases requiring hospitalization decreased and the proportion 
of HF cases diagnosed in outpatient clinics increased. HF, especially following AMI 
discharge remained an important source of excessive mortality.   
Trends in the risk of heart failure 
In line with our findings, the risk of in-hospital HF declined among AMI patients in 
Sweden (from 46% in 1996 to 26.6% in 2008) 10 and in Western Australia (from 21.7% in 
1996-1998 to 12.1% in 2005-2007) 8. In Norway, the risk of in-hospital HF increased by 20% 
from 2001 to 2009 23.  
Post-discharge HF rates declined by 14.6% in USA (1998-2010) 15 and 6.3% per year in 
Norway (2001-2009) 23. In Italy, one-year risk of HF following an incident AMI remained 
stable during 2001-2011 24. The only study conducted previously in Denmark reported a 
decline of 23% in risk of HF within 90 days from incident AMI discharge (1997-2010) 9. 
Beside differences in the length of follow up, other methodological issues may account for 
differences in results between our study and that published by Gjesing et al.9. We defined 
incident episodes of HF as new hospitalizations or outpatients contacts while in the previous 
study, Gjesing et al.9 combined a discharge diagnosis of HF with use of loop diuretics.   
Many factors can influence the risk of HF among AMI patients. The use of PCI within 30 
days of hospitalization increased substantially during 1999-2008 in Denmark 9. Over the same 
period, there was a significant increase in the use of cardiac drugs, including beta-blockers, 
statins, inhibitors of the renin-angiotensin system and antiplatelet agents among AMI patients 
9 as well as in the general population 25. The increase in the utilization of these drugs 
contribute in the reduction of HF risk through at least two mechanisms. First, use of cardiac 
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therapy prior to an AMI has shown to reduce the severity of AMI expression 26, thus reducing 
the risk of early HF. Second, in patients with AMI, increases in the use of evidence-based 
therapy have the potential to reduce the risk of adverse events, including ischemic recurrences 
and post-discharge HF. Further contribution in HF risk reduction may have been provided by 
declines in the prevalence of smoking, hypertension and hypercholesterolemia 27.  
Of note, the risk of post-discharge HF requiring hospitalization and that of post-discharge HF 
diagnosed at outpatient clinics went in opposite directions. The proportion of outpatient 
contacts within all HF cases varied widely; from 13.2% in Minnesota 28 to 50% in Canada 29. 
In our study, the outpatient contacts accounted for 31.1% of all post-discharge HF cases. We 
did not observe differences between groups with regard to AMI severity but patients who later 
experienced a HF episode requiring hospitalization had a greater burden of comorbidities at 
baseline compared to those diagnosed with HF in outpatient clinics. It is plausible that the 
presence of these comorbidities has an influence on the decision to hospitalize patients as 
hospitals offer a more convenient setting for diagnosing and/or treating comorbidities. The 
opposite trends in post-discharge HF requiring hospitalization and those diagnosed at 
outpatient clinics may have several explanations. The increase over time in the proportion of 
outpatient contacts corresponded with an increase in the number of outpatient heart failure 
clinics affiliated to Danish hospitals. An increased use of echocardiographic imaging and 
surveillance of HF over time in a period in which there has been great improvement in 
treatment of heart failure may have led to diagnosing HF at an early stage, preventing thus the 
need for hospitalization. The shorter time from AMI discharge to HF diagnosis among 
outpatient contacts compared to hospitalized cases in our study supports this hypothesis. 
Other possible explanation involve financial and availability constrains that hospital are 




Excess mortality associated with HF 
Our study confirms previous findings of an excess early mortality associated with in-hospital 
HF among various subsets of acute coronary patients 30-32. The excess one-year mortality 
associated with post-discharge HF in our study was similar to that observed among acute 
coronary syndrome patients in Canada during 2002-2008 29 and Norway during 2001-2009 16. 
Despite overall improvement in survival following an AMI in Denmark 33, HF remains a 
source of excessive mortality. The HF correlates with the extension of CHD and was 
associated in our study with higher incidence of pulmonary edema, cardiogenic shock and AV 
blocks. Patients with HF had also a greater burden of comorbidities and received less often 
invasive coronary procedures compared to those without HF (data not shown). This finding is 
in line with previous publications 31 34. However, due to the observational nature of our study 
and lack of date for in-hospital HF, we cannot establish a temporal relationship between 
myocardial revascularization and in-hospital HF. It seems plausible that certain comorbidities 
may represent contraindication to invasive interventions. Further, the rates of success of 
revascularization procedures are lower among patients with, compared to those without in-
hospital HF 35. 
Although accounting for the minority of all HF cases, post-discharge HF in the context of 
CHD conveys a far greater excess mortality compared to that of in-hospital HF. Therefore, 
focused efforts on identification of factors associated with post-discharge HF would help 
reducing the mortality in this subset of AMI patients. 
Strength and limitations 
Our study included all individuals with an incident AMI in Denmark, without age, gender or 
geographical restrictions, maximizing thus the generalizability of our findings. The study 
period followed the introduction of troponin in AMI diagnostic criteria in Denmark (around 
year 2000); therefore, our results are minimally, if at all, influenced by changes in the AMI’s 
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diagnostic criteria. We excluded with high probability previous episodes of AMI and HF 
using a fairly long retrospective search of five years 36, avoiding the mixture of incident with 
prevalent AMI. Our study is the first to include in the analyses and separately analyze trends 
in the risk of HF diagnosed as outpatient contacts. 
Our study carries some limitations inherent to the nature of data sources. No information on 
some relevant lifestyle factors such as smoking, obesity, physical activity and lipid profile 
was available. No information on echocardiographic evaluation of ventricular function and/or 
number of vessels involved and degree of stenosis was available either. A distinction between 
ST-elevation MI (STEMI) and non ST-elevation MI (NSTEMI) based on the ICD-10 coding 
system was not possible. However, previous analyses have revealed that the excess mortality 
associated with HF among AMI patients did not differ by HF type (3.5 times higher for HF 
with reduced ejection fraction versus 3.1 times higher for HF with preserved ejection fraction; 
Pheterogeneity =0.31) 14. Other studies conducting stratified analyses for STEMI and NSTEMI 
have shown that the magnitude and time trends of HF complicating the two AMI types are 
similar 10 37 38. 
Lastly, many factors such as the study period, methodological differences in defining the 
study population and/or ascertaining the outcome, as well as the quality of register data can 
potentially influence the findings, however we are not able to quantify such influence. 
Conclusions: In patients hospitalized with an incident AMI during 2000-2009, we observed a 
modest decline over time in the risk of in-hospital HF while the risk of post-discharge HF did 
not change. When complicating AMI, HF conveys an increased risk of death, more 
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Flow chart of study participants 
Figure 2 
Changes in the adjusted odds of in-hospital heart failure among patients hospitalized with an 
incident acute myocardial infarction in Denmark during 2000-2009 
Figure 3 
Changes in the adjusted risk of post-discharge heart failure requiring hospitalization (a) or 
diagnosed at outpatient clinics (b) among patients hospitalized with an incident acute 





















 (n= 78 814) 
 2000-2001 




 (n=16 174) 
 2006-2007 
 (n=14 893) 
 2008-2009 
(n=14 463) 
            
Male gender, % 63.9  63.1  63.4  63.7  64.3  65.2 
Age (years), mean (SD) 69.3 (12.8)  69.5 (12.5)  69.6 (12.7)  69.5 (12.9)  69.0 (13.0)  69.1 (13.1) 
Previous history of CHD, % 9.9  9.3  10.4  10.1  10.0  9.5 
Comorbidities, %            
 Diabetes mellitus 13.3  12.4  13.3  13.6  13.7  13.8 
 Hypertension 26.2  15.4  22.5  27.7  32.7  34.3 
 Renal failure 2.9  2.1  2.5  3.0  3.4  3.6 
 Chronic obstructive pulmonary disease 8.4  7.8  8.6  8.5  8.4  8.6 
 Valvular heart disease 4.5  3.1  4.2  4.9  5.0  5.6 
 Atrial fibrillation 10.2  9.0  10.0  10.5  10.3  11.3 
Complications of AMI, %            
 Ventricular fibrillation 0.5  0.4  0.6  0.5  0.6  0.6 
 Pulmonary oedema 0.7  0.7  0.8  0.7  0.7  0.4 
 Cardiogenic shock 0.6  0.6  0.6  0.7  0.7  0.6 
 Atrioventricular block ( 2nd or 3d degree) 0.9  0.9  0.9  0.8  0.9  0.8 
 Mechanical complications 0.3  0.4  0.3  0.3  0.3  0.2 
Invasive coronary procedures, %            
 Coronary angiography 52.4  24.1  46.3  57.7  65.3  72.1 
 Percutaneous coronary intervention 36.6  14.6  31.2  41.7  47.7  50.7 
 Coronary artery bypass graft 4.5  3.9  5.0  4.5  4.5  4.4 
 Any revascularization 41.7  22.0  37.1  46.0  51.4  54.4 
CHD: coronary heart disease 
AMI: acute myocardial infarction                         
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Table 2. The proportion of study population developing heart failure or dying during the follow up in Denmark during 2000-2009 
Study outcomes Age categories 
        
 All ages  40-59 years  60-79 years  80+ years 
In-hospital outcomes, n (%)  (n=78 814)   (n=19 385)   (n=39 754)   (n=19 675) 
In-hospital heart  failure 10 248 (13.0)  1203 (6.2)  5214 (13.1)  3831 (19.5) 
In-hospital deaths 8449 (10.7)  578 (3.0)  3671 (9.2)  4200 (21.3) 
        
Post-discharge outcomes*, n (%)  (n= 61 637)   (n=17 674)   (n=31 547)   (n=12 416) 
Post-discharge heart failure 5978 (9.7)  975 (5.5)  3215 (10.2)  1788 (14.4) 
 Hospitalizations 4116 (6.7)  512 (2.9)  2127 (6.7)  1477 (11.9) 
 Outpatient contacts 1862 (3.0)  463 (2.6)  1088 (3.5)  311 (2.5) 
Post-discharge deaths 5925 (9.6)  341 (1.9)  2398 (7.6)  3186 (25.7) 
 













Table 3.  The adjusted* excess early (in-hospital and 30-day) mortality associated with in-hospital 
heart failure among patients hospitalized with an incident acute myocardial infarction in Denmark, 
2000-2009 
 
Study period  In-hospital heart failure  Odds ratio  
(95% CI) 
Pinteraction** 







       
 2000-2009  68 566/6929 (10.1)  10 248/1520 (14.8)  1.13 (1.06-1.20) 0.001 
  2000-2001  14 052/1775 (12.6)  2065/318 (15.4)  0.88 (0.77-1.01)  
  2002-2003  14 879/1584 (10.7)  2288/362 (15.8)  1.11 (0.97-1.27)  
  2004-2005  14 050/1352 (9.6)  2124/347 (16.3)  1.32 (1.15-1.51)  
  2006-2007  13 058/1241 (9.5)  1835/261 (14.2)  1.16 (1.00-1.35)  
  2008-2009  12 527/977 (7.8)  1936/232 (12.0)   1.24 (1.06-1.46)  
30-day  
mortality 
       
 2000-2009  68 566/7837 (11.4)  10 248/1733 (16.9)  1.14 (1.07-1.20) 0.003 
  2000-2001  14 052/1957 (13.9)  2065/364 (17.6)  0.92 (0.81-1.04)  
  2002-2003  14 879/1780 (12.0)  2288/422 (18.4)  1.17 (1.03-1.33)  
  2004-2005  14 050/1561 (11.1)  2124/391 (18.4)  1.28 (1.12-1.46)  
  2006-2007  13 058/1394 (10.7)  1835/279 (15.2)  1.08 (0.93-1.26)  
  2008-2009  12 527/1145 (9.1)  1936/277 (14.3)   1.26 (1.08-1.46)  
* Adjusted for age, gender, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, 
valvular heart disease, renal failure and atrial fibrillation. 











Table 4.  The adjusted* excess one-year mortality associated with post-discharge heart failure among 
patients hospitalized with an incident acute myocardial infarction in Denmark, 2000-2009 
 










2000-2009  55 659/4731 (8.5)  5978/1194 (20.0)  3.39 (3.18-3.63) 0.008 
 2000-2001  11 113/994 (8.9)  1164/273 (23.5)  4.31 (3.75-4.96)  
 2002-2003  12 028/1057 (8.8)  1267/255 (20.1)  3.11 (2.69-3.60)  
 2004-2005  11 457/945 (8.3)  1241/251 (20.2)  3.50 (3.02-4.05)  
 2006-2007  10 692/867 (8.1)  1125/199 (17.7)  3.05 (2.60-3.59)  
 2008-2009  10 369/868 (8.4)  1181/216 (18.3)  3.11 (2.67-3.63)  
* Adjusted for age, gender, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, 
valvular heart disease, renal failure and atrial fibrillation. 
** Interaction between in-hospital heart failure and year of the incident acute myocardial infarction. 
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Figure 2 
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Figure 3 
 
 
